The global pharmaceutical landscape is undergoing a seismic shift towards Decentralized Clinical Trials (DCT), and Milan, the heart of Italy's life sciences sector, is at the forefront of this revolution. As a leading manufacturer of DCT solutions, we recognize that the Milanese market—anchored by the Milano Innovation District (MIND) and the Human Technopole—demands more than just equipment; it requires a integrated ecosystem of digital health tools, remote monitoring devices, and robust diagnostic reagents.
Decentralization removes the traditional "site-centric" barriers, allowing patients across the Lombardy region to participate in groundbreaking research from the comfort of their homes. This shift increases Information Gain by capturing real-world data (RWD) that is often missed in sterile clinical environments. Our manufacturing excellence ensures that Milan-based Clinical Research Organizations (CROs) have access to ISO-certified, high-precision diagnostic cleaning solutions and remote monitoring hardware that meet the rigorous standards of the European Medicines Agency (EMA).
Dongguan Trial Medical Co., Ltd. is a specialized manufacturer of remote clinical trial monitoring devices, decentralized clinical trial solutions, and digital research technologies. Established in 2016, the company is located in Dongguan, China, a major center for advanced manufacturing, medical technology development, and electronic innovation.
Operating from a modern facility covering more than 11,000 square meters, with a team of over 230 employees, Trial Medical is dedicated to developing and manufacturing innovative technologies that support clinical research organizations, pharmaceutical companies, healthcare institutions, and academic research centers worldwide.
Supported by an experienced team of engineers, software developers, and quality management professionals, Trial Medical continuously invests in research and development to address the evolving needs of modern clinical studies. The company integrates advanced connectivity technologies, cloud-based data management capabilities, and intelligent monitoring functions to support reliable and scalable clinical research operations.
Our roadmap for 2024-2026 focuses on the convergence of Artificial Intelligence (AI) and the Internet of Medical Things (IoMT). For the Milan market, this means providing solutions that are fully compliant with GDPR and local Italian healthcare regulations. We are pioneering electronic Clinical Outcome Assessment (eCOA) platforms that sync seamlessly with our diagnostic reagents and analyzers, ensuring data integrity from the patient's bedside to the researcher's dashboard.
Utilizing China's Industry 4.0 infrastructure, we offer unparalleled efficiency in the production of high-purity diagnostic solutions (like our Acid Wash and Substrate solutions). Our automated production lines reduce human error, while our strategic location in Dongguan ensures a resilient supply chain that can pivot to meet the urgent needs of the European market, bypassing traditional logistics bottlenecks.
For global enterprises looking to procure for Milan-based clinical sites, we offer OEM and ODM services. We understand that clinical trials require customized reagents and packaging to fit specific analyzer models like Toshiba, Roche, and Beckman Coulter. Our high-efficiency GMP purified water treatment and aseptic capping technologies ensure that every bottle delivered to your Milan lab is sterile and reliable.
Contact Dongguan Trial Medical today to discuss your specific decentralized clinical trial needs, from remote patient monitoring to specialized clinical biochemistry reagents.
Trial Medical
